XML 52 R33.htm IDEA: XBRL DOCUMENT
v3.20.4

Revenues (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2020
Revenues [Abstract] |
Schedule of net product revenues by product | The Company’s net product revenues consisted of the following for the years ended December 31:
|  | 2020 |  | 2019 |  | 2018
Products: |  |  |  |  |  |
Kristalose |  | $ | 15,567,562 |  |  | $ | 12,895,120 |  |  | $ | 12,055,625 |
Vibativ |  | 10,870,990 |  |  | 8,691,550 |  |  | 5,075,057 |
Caldolor |  | 5,336,943 |  |  | 5,222,282 |  |  | 5,001,997 |
Acetadote |  | 1,874,206 |  |  | 3,824,449 |  |  | 4,284,111 |
Omeclamox-Pak |  | 257,088 |  |  | 837,829 |  |  | 623,297 |
Vaprisol |  | 1,077,227 |  |  | 936,615 |  |  | 1,763,874 |
RediTrex |  | 856,657 |  |  | — |  |  | — |
Total net product revenues |  | $ | 35,840,673 |  |  | $ | 32,407,845 |  |  | $ | 28,803,961 |

X
- References No definition available. + Details
Name: | us-gaap_RevenuesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599 + Details
Name: | us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration